What is it used for?
IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- tarlatamab-dlletarlatamab-dlle
- Form and strength
- KITKIT
- Manufacturer / applicant
- AMGEN, INCAMGEN, INC
For injection: 1 mg of white to slightly yellow lyophilized powder in a single-dose vial for reconstitution and further dilution. For injection: 10 mg of white to slightly yellow lyophilized powder in a single-dose vial for reconstitution and …For injection: 1 mg of white to slightly yellow lyophilized powder in a single-dose vial for reconstitution and further dilution. For injection: 10 mg of white to slightly yellow lyophilized powder in a single-dose vial for reconstitution and …
Safety and clinical review
Cytokine release syndrome (CRS), including life-threatening or fatal reactions, can occur in patients receiving IMDELLTRA. Initiate IMDELLTRA using the step-up dosing schedule to reduce the incidence and severity of CRS. Withhold IMDELLTRA until CRS resolves or permanently discontinue based on severity . …Cytokine release syndrome (CRS), including life-threatening or fatal reactions, can occur in patients receiving IMDELLTRA. Initiate IMDELLTRA using the step-up dosing schedule to reduce the incidence and severity of CRS. Withhold IMDELLTRA until CRS resolves or permanently discontinue based on severity . …
- Cytokine Release Syndrome (CRS)Cytokine Release Syndrome (CRS)
- Neurologic Toxicity Including ICANSNeurologic Toxicity Including ICANS
- CytopeniasCytopenias
- InfectionsInfections
- HepatotoxicityHepatotoxicity
- HypersensitivityHypersensitivity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Imdelltra used for?
IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
What determines the price of Imdelltra?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Imdelltra?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.